NEW YORK, July 17 – Nanogen and Aventis Research and Technologies have formed a joint venture, Nanogen Recognomics, to develop new products and applications for Nanogen’s NanoChip SNP analysis system, Nanogen said Tuesday.

The new Frankfurt-based company, 60 percent owned by Nanogen and 40 percent by Aventis R&T, will focus on developing genetic-based diagnostics, screening, and detection techniques, including those using novel oligonucleotide attachment chemistries.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.